Generic drug of the therapeutic class: Ophthalmology
active ingredients: Betaxolol
Dropper bottle of 3 ml
- Chronic open angle glaucoma.
- Intraocular hypertonia.
Dosage BETOPTIC 0, 5% Ophthalmic suspension Dropper bottle of 3 ml
The recommended dosage is one drop of Betoptic 0.5% in the sick eye, twice a day (morning and evening).
In some patients, the normalization of intraocular pressure by Betoptic 0.5% sometimes requires a few weeks, so the evaluation of treatment should include an intraocular pressure determination after a treatment period of one month. . Subsequently, the control of intraocular pressure will be performed according to the patient, according to a frequency left to the discretion of the doctor.
- Because of normal nycthemeral variations in intraocular pressure, it is best to evaluate the effectiveness of treatment by measuring blood pressure at different times of the day.
- In the case where Betoptic 0.5% has to take over from previous antiglaucoma treatment, overlay both treatments for one day. The next day, you can remove the previous treatment and continue with Betoptic 0.5% alone.
- When you have to substitute Betoptic 0.5% for several antiglaucoma medications, the doctor can, depending on the case, interrupt some or decide to stop them all. However, the deletions will be successive and must involve only one drug at a time, with an interval of at least one week between two successive deletions.
- The ophthalmologist may, if he considers it necessary, associate with the treatment:
. either sympathol or parasympathomimetic antiglaucoma eye drops,
. either a systemic treatment with a carbonic anhydrase inhibitor, to obtain a maximal result.
- The patient will strictly adhere to the medical prescription that will be accompanied by the monitoring of intraocular pressure, especially during the period of adjustment of the dosage.
- Hypersensitivity to any of the components of the eye drops.
- Uncontrolled congestive heart failure.
- High degree atrioventricular block (not paired).
- Significant Bradycardia (<45 to 50 beats / min).
NOT RECOMMENDED :
- Use in children: absence of pediatric clinical studies.
- Breast-feeding: the possibility of a passage in the milk has not been studied.
Betoptic side effects
- Adverse effects related to systemic effects of beta-blockers are rare (see contraindications, warnings and precautions for use). Cases of insomnia and depression have been observed.
- A slight uncomfortable sensation of short duration can be observed occasionally at instillation.
- A few cases of tearing, conjunctival hyperemia, superficial punctate keratitis and photophobia have been reported.
- Rare cases of anisocoria and decreased corneal sensitivity have been observed.